News

Featured News

  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | December 18, 2018

    Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

    Read More

    Press Release | December 18, 2018

    Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

    Read More

    Press Release | December 13, 2018

    Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

    Read More

    Press Release | December 6, 2018

    Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

    Read More

    News | November 27, 2018

    Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

    Read More

    News | November 20, 2018

    Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

    Read More

    News | November 5, 2018

    Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering

    Read More

    Press Release | July 16, 2018

    Pliant Therapeutics Raises $62 Million in Series B Financing

    Read More

    Press Release | July 16, 2018

    Verge Genomics Announces $32 Million Series A

    Read More

    News | June 27, 2018

    Carisma Nabs $53 Million Series A for Cellular Cancer Therapy

    Read More

    Press Release | June 26, 2018

    Skyhawk Therapeutics Announces $40 Million Equity Investment Round

    Read More

    News | June 26, 2018

    Kauffman Fellows Celebrates Its Most Diverse Group of Talented Leaders With Class 23

    Read More

    News | June 26, 2018

    Genome Editing Startup Precision BioSciences Scores $110 Million Series B

    Read More

    Press Release | June 26, 2018

    Precision BioSciences Raises $110M

    Read More

    News | June 26, 2018

    Skyhawk Therapeutics Gains $100 Million Through Venture Round, Collaboration

    Read More

    News | June 26, 2018

    CAR Macrophage Tumor Tech Created by UPenn Star Scientists Gets $53M

    Read More

    Press Release | June 20, 2018

    Aptinyx Announces Pricing of Initial Public Offering

    Read More

    News | April 12, 2018

    UK Gene Therapy Firm Orchard Plans Stock Offer After GSK Deal

    Read More